HEPATITIS B VIRUS CORE PROTEIN AND SURFACE ANTIGEN PROTEIN AND VACCINE COMPRISING THE SAME
The following summary describes a Laos Patent titled “HEPATITIS B VIRUS CORE PROTEIN AND SURFACE ANTIGEN PROTEIN AND VACCINE COMPRISING THE SAME”, filed by THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA on 2013-09-19; current status: Registered. Identifiers include application No. P/354; DIP id LAP354; protection kind Patent - PCT National Phase. Key dates: publication 2023-04-14; grant 2023-04-11; expiry reference 2033-09-19. Classification: A61K 39/29、C12N 1/21、C12N 15/09、C12N 15/63、C12N 5/10. Inventor(s)/designer(s): OBENG-ADJEI, Nyamekye, WEINER, David, B, YAN, Jian. Abstract hint: Provided herein are nucleic acid sequences encoding hepatitis B virus (HBV) core proteins, surfacea antigen proteins, fragments and combina…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
P/354
Mark
Key facts
- Type
- Patent
- App. no.
P/354- Status
- Registered
- Applicant
- THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
- Agent
- CONCETTI-LAO CO., LTD
- Filing date
- 2013-09-19
- Reg. no.
P/354- Publication
- 2023-04-14
- Registration / grant
- 2023-04-11
- Expiry
- 2033-09-19
- Protection kind
- Patent - PCT National Phase
- Gazette
- 202 · 2023-04-14
- Applicant address
- THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA · 3160 Chestnut Street, Suite 200, Philadelphia, Pennsylvania 19104-6283, United States Of America · US
- Agent address
- CONCETTI-LAO CO., LTD · Lao-Thai Friendship Road, Sokpaluang Village,Sisattanak District, Vientiane Lao PDR · LA
- Nice / IPC classes
- A61K 39/29 · C12N 1/21 · C12N 15/09 · C12N 15/63 · C12N 5/10
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
ສະໜອງທີ່ນີ້ແມ່ນອາຊິດ ນີວກະເລໂອຕິດ ລໍາດັບ ການເຂົ້າລະຫັດ ໄວຣັດອັກເສບຕັບ B ໄວລັດ(HBV) ຫຼັກໂປຼຕີນ, ໜ້າພຽງຕົວຕ້ານໂປຼຕີນ, ພາກສ່ວນຍ່ອຍ ແລະ ການປະສົມປະສານ ເຫຼົ່ານີ້ເຊັ່ນດຽວກັບການກໍາມະພັນ/ບັນດາເວັກເຕີ ແລະ ວັກຊີນນັ້ນອະທິບາຍໂປຼຕີນລໍາດັບທີ່ກ່າວ. ວັກຊີນແມ່ນສາມາດກະຕຸ້ນການຕອບສະໜອງພູມຄຸ້ມກັນຢ່າງຕໍ່ພວງໜຶ່ງ ແລະ ໃນຕັບດ້ວຍເຮັດອອກໃຫ້ເຫັນທັງສອງແຊນລຸຍລາ ແລະ ຕົວຂອງແຫຼວສໍາລັບຮ່າງກາຍ. ຍັງສະໜອງແມ່ນບັນດາວິທີການສໍາລັບການປ້ອງກັນໂລກ ແລະ/ຫຼື ການຮັກສາໂລກ ພູມຕ້ານທານສ່ວນຕົວຕໍ່ HBV. ການປະສົມປະສານວັກຊີນອາດຍັງໄດ້ຖືກນໍາໃຊ້ສໍາລັບພາກສ່່ວນອອກແບບວັກຊິນສໍາລັບລະດັບສະເພາະຂອງພູມຕ້ານທານຕອບສະໜອງຫາການທ້າທາຍ HBV.
Provided herein are nucleic acid sequences encoding hepatitis B virus (HBV) core proteins, surfacea antigen proteins, fragments and combinations thereof as well as genetic constructs/vectors and vaccines that express said protein sequences. These vaccines are able to induce an immune response peripherally and in the liver by recruiting both cellular and humoral agents. Also provided are methods for prophylactically and/or therapeutically immunizing individuals against HBV. The combination Vaccine can also be used for particular design vaccines for particular levels of immune responses to HBV challenge.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP354.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP354.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP354.html?lang=en · CC BY 4.0